T2DM is an autoimmune and preventable disease, characterized by impaired/absence of insulin signaling, and is associated with various degrees of pancreatic β-cell failure in hepatic, adipose and muscle tissues, as well as reduced insulin sensitivity, leading to endocrine abnormalities and persistent hyperglycemia [1,2]. This evidence concerns the gene INS and type 2 diabetes mellitus.